Trial
NCT02802514
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
The General Hospital Corporation d/b/a Massachusetts General Hospital
Condition
Diabetes Mellitus
Intervention
Albiglutide 50mg
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-30